BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 17493754)

  • 1. Development and validation of the Current Opioid Misuse Measure.
    Butler SF; Budman SH; Fernandez KC; Houle B; Benoit C; Katz N; Jamison RN
    Pain; 2007 Jul; 130(1-2):144-56. PubMed ID: 17493754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.
    Butler SF; Budman SH; Fanciullo GJ; Jamison RN
    Clin J Pain; 2010; 26(9):770-6. PubMed ID: 20842012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
    Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
    Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation and validation of the Chinese version of the Current Opioid Misuse Measure (COMM) for patients with chronic pain in Mainland China.
    Zhao Y; Li Y; Zhang X; Lou F
    Health Qual Life Outcomes; 2015 Sep; 13():147. PubMed ID: 26374505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9.
    McCaffrey SA; Black RA; Villapiano AJ; Jamison RN; Butler SF
    Pain Med; 2019 Jan; 20(1):113-118. PubMed ID: 29237039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).
    Butler SF; Fernandez K; Benoit C; Budman SH; Jamison RN
    J Pain; 2008 Apr; 9(4):360-72. PubMed ID: 18203666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
    Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
    Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
    Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
    Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care.
    Jamison RN; Martel MO; Huang CC; Jurcik D; Edwards RR
    J Pain; 2016 Apr; 17(4):414-23. PubMed ID: 26705974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adapting the Current Opioid Misuse Measure (COMM) for people with chronic pain and disability due to arthritis: The development of the COMM 11-PWDA.
    Mallery Lankford C; Paez K; Yang M; Lin A
    Disabil Health J; 2022 Jun; 15(2S):101296. PubMed ID: 35414483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a screener and opioid assessment measure for patients with chronic pain.
    Butler SF; Budman SH; Fernandez K; Jamison RN
    Pain; 2004 Nov; 112(1-2):65-75. PubMed ID: 15494186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance.
    Compton PA; Wu SM; Schieffer B; Pham Q; Naliboff BD
    J Pain Symptom Manage; 2008 Oct; 36(4):383-95. PubMed ID: 18508231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain?
    Moryl N; Mendoza TR; Horn SD; Eustaquio JC; Cleeland CS; Inturrisi C
    J Natl Compr Canc Netw; 2023 Nov; 21(11):1132-1140.e3. PubMed ID: 37935105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a brief Opioid Compliance Checklist for patients with chronic pain.
    Jamison RN; Martel MO; Edwards RR; Qian J; Sheehan KA; Ross EL
    J Pain; 2014 Nov; 15(11):1092-1101. PubMed ID: 25092233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?
    Wasan AD; Butler SF; Budman SH; Fernandez K; Weiss RD; Greenfield SF; Jamison RN
    Clin J Pain; 2009; 25(3):193-8. PubMed ID: 19333168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP
    Varney SM; Perez CA; Araña AA; Carey KR; Ganem VJ; Zarzabal LA; Ramos RG; Bebarta VS
    Intern Emerg Med; 2018 Dec; 13(8):1239-1247. PubMed ID: 29502329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.
    Jamison RN; Ross EL; Michna E; Chen LQ; Holcomb C; Wasan AD
    Pain; 2010 Sep; 150(3):390-400. PubMed ID: 20334973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of opioid problems among chronic pain patients in a general medical population.
    Banta-Green CJ; Merrill JO; Doyle SR; Boudreau DM; Calsyn DA
    Drug Alcohol Depend; 2009 Sep; 104(1-2):43-9. PubMed ID: 19473787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain.
    Barth KS; Balliet W; Pelic CM; Madan A; Malcolm R; Adams D; Morgan K; Owczarski S; Borckardt JJ
    Pain Med; 2014 Aug; 15(8):1359-64. PubMed ID: 24716629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in risk factors for aberrant prescription opioid use.
    Jamison RN; Butler SF; Budman SH; Edwards RR; Wasan AD
    J Pain; 2010 Apr; 11(4):312-20. PubMed ID: 19944648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.